246 related articles for article (PubMed ID: 18949619)
21. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
Zhou L; Nguyen AN; Sohal D; Ying Ma J; Pahanish P; Gundabolu K; Hayman J; Chubak A; Mo Y; Bhagat TD; Das B; Kapoun AM; Navas TA; Parmar S; Kambhampati S; Pellagatti A; Braunchweig I; Zhang Y; Wickrema A; Medicherla S; Boultwood J; Platanias LC; Higgins LS; List AF; Bitzer M; Verma A
Blood; 2008 Oct; 112(8):3434-43. PubMed ID: 18474728
[TBL] [Abstract][Full Text] [Related]
24. A paradigm shift in myelodysplastic syndromes.
Raza A; Mundle S; Shetty V; Alvi S; Chopra H; Span L; Parcharidou A; Dar S; Venugopal P; Borok R; Gezer S; Showel J; Loew J; Robin E; Rifkin S; Alston D; Hernandez B; Shah R; Kaizer H; Gregory S; Preisler H
Leukemia; 1996 Oct; 10(10):1648-52. PubMed ID: 8847900
[TBL] [Abstract][Full Text] [Related]
25. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.
Shetty V; Mundle S; Alvi S; Showel M; Broady-Robinson L; Dar S; Borok R; Showel J; Gregory S; Rifkin S; Gezer S; Parcharidou A; Venugopal P; Shah R; Hernandez B; Klein M; Alston D; Robin E; Dominquez C; Raza A
Leuk Res; 1996; 20(11-12):891-900. PubMed ID: 9009245
[TBL] [Abstract][Full Text] [Related]
26. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.
Raza A; Mundle S; Shetty V; Alvi S; Chopra H; Span L; Parcharidou A; Dar S; Venugopal P; Borok R; Gezer S; Showel J; Loew J; Robin E; Rifkin S; Alston D; Hernandez B; Shah R; Kaizer H; Gregory S
Int J Hematol; 1996 Jun; 63(4):265-78. PubMed ID: 8762810
[TBL] [Abstract][Full Text] [Related]
27. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
28. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
29. Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice.
Wagner PN; Shi Q; Salisbury-Ruf CT; Zou J; Savona MR; Fedoriw Y; Zinkel SS
Blood; 2019 Jan; 133(2):107-120. PubMed ID: 30413413
[TBL] [Abstract][Full Text] [Related]
30. p38 MAP kinase inhibitors: many are made, but few are chosen.
Dominguez C; Powers DA; Tamayo N
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):421-30. PubMed ID: 16022178
[TBL] [Abstract][Full Text] [Related]
31. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
[TBL] [Abstract][Full Text] [Related]
32. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
Kumar S; Votta BJ; Rieman DJ; Badger AM; Gowen M; Lee JC
J Cell Physiol; 2001 Jun; 187(3):294-303. PubMed ID: 11319753
[TBL] [Abstract][Full Text] [Related]
33. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
[TBL] [Abstract][Full Text] [Related]
34. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
[TBL] [Abstract][Full Text] [Related]
35. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.
Mei Y; Zhao B; Basiorka AA; Yang J; Cao L; Zhang J; List A; Ji P
Leukemia; 2018 Apr; 32(4):1023-1033. PubMed ID: 29263441
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of oral ARRY-614, a p38 MAPK/Tie2 dual inhibitor, in patients with low or intermediate-1 risk myelodysplastic syndromes.
Garcia-Manero G; Khoury HJ; Jabbour E; Lancet J; Winski SL; Cable L; Rush S; Maloney L; Hogeland G; Ptaszynski M; Calvo MC; Bohannan Z; List A; Kantarjian H; Komrokji R
Clin Cancer Res; 2015 Mar; 21(5):985-94. PubMed ID: 25480830
[TBL] [Abstract][Full Text] [Related]
37. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow.
Pecci A; Travaglino E; Klersy C; Invernizzi R
Acta Haematol; 2003; 109(1):29-34. PubMed ID: 12486320
[TBL] [Abstract][Full Text] [Related]
39. Signal transduction inhibitors in treatment of myelodysplastic syndromes.
Bachegowda L; Gligich O; Mantzaris I; Schinke C; Wyville D; Carrillo T; Braunschweig I; Steidl U; Verma A
J Hematol Oncol; 2013 Jul; 6():50. PubMed ID: 23841999
[TBL] [Abstract][Full Text] [Related]
40. Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.
Nakao T; Kim S; Ohta K; Kawano H; Hino M; Miura K; Tatsumi N; Iwao H
Br J Pharmacol; 2002 Aug; 136(7):975-84. PubMed ID: 12145097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
